The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
COVID-19 pandemic response
We continue to follow Government and University of Cambridge guidelines for staying COVID-safe. Our buildings are open for lab-based research work.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Wellcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
Congratulations to Giles Yeo who has been awarded the 2022 Society Medal of the Society for Endocrinology. The Medal of the Society for Endocrinology…
How do you work out what stimulates release of a hormone which isn’t expressed in rodents or cell lines, and is challenging to measure…
A blog post by Professor Sir Stephen O’Rahilly. Great to see our paper appear online today at Nature. This was the result of a…
Researchers from the MRC Metabolic Diseases Unit and the MRC Epidemiology Unit have discovered how a receptor in the brain detects the nutritional state…